Position in JNJ
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$4,253,489
+$323,628 QoQ
Shares Held
16,748
+4.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.40%
of 13F equity value
Holder Rank
#1,730
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 81%
Shared 19%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pinnacle Bancorp, Inc. holds $17,238,730 across 16 Drug Manufacturers - General names. JNJ ranks #2 (24.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,700 | $6,836,751 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
16,748 | $4,253,489 | |
| 3 | ABBV |
AbbVie Inc.
|
12,680 | $3,190,795 | |
| 4 | MRK |
Merck & Co., Inc.
|
9,566 | $1,229,231 | |
| 5 | NVS |
Novartis AG
|
3,551 | $556,512 | |
| 6 | PFE |
Pfizer Inc
|
21,473 | $517,069 | |
| 7 | AMGN |
Amgen Inc
|
487 | $176,352 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
2,289 | $131,892 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,253,489 | 16,748 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $3,929,861 | 16,077 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $3,292,988 | 15,912 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $2,984,149 | 16,094 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $2,432,391 | 15,924 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $2,713,805 | 16,364 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $2,408,356 | 16,653 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $2,710,129 | 16,723 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $2,304,650 | 15,768 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $2,709,478 | 17,128 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $2,445,144 | 15,600 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $2,446,209 | 15,706 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $2,695,824 | 16,287 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $2,485,270 | 16,034 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $2,824,633 | 15,990 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $2,684,821 | 16,435 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $2,918,086 | 16,439 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $2,931,915 | 16,543 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $2,710,262 | 15,843 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $2,573,018 | 15,932 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $2,622,660 | 15,920 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $2,618,588 | 15,933 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $2,566,710 | 16,309 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $2,462,028 | 16,537 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $2,441,618 | 17,362 | Shares | Sole | 2020-07-07 | |
| 2020-03-31 | $2,285,858 | 17,432 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||